Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myeloid leukemia

Fathi, AT; Arévalo, M; Gutierrez, S; Molero, A; Sacilotto, N; Limon, AE; Faller, DV

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):